Search Results - "Wang, Katy"

Refine Results
  1. 1

    Tivozanib mediated inhibition of c-Kit/SCF signaling on Tregs and MDSCs and reversal of tumor induced immune suppression correlates with survival of HCC patients by Kalathil, Suresh Gopi, Wang, Katy, Hutson, Alan, Iyer, Renuka, Thanavala, Yasmin

    Published in Oncoimmunology (01-01-2020)
    “…The immune modulatory effect of tivozanib, a tyrosine kinase inhibitor, and the underlying immune mechanisms impacting survival of HCC patients have not been…”
    Get full text
    Journal Article
  2. 2

    Testicular, Spermatic Cord, and Scrotal Soft Tissue Sarcomas: Treatment Outcomes and Patterns of Failure by Chowdhry, Varun K., Kane, John M., Wang, Katy, Joyce, Daniel, Grand’Maison, Anne, Mann, Gary N.

    Published in Sarcoma (2021)
    “…Introduction. Paratesticular sarcomas are defined as tumors that arise within the scrotum and include the subsites of epididymis, spermatic cord, and tunica…”
    Get full text
    Journal Article
  3. 3

    Impact of Firearm Availability and Gun Regulation on State Suicide Rates by Kposowa, Augustine, Hamilton, David, Wang, Katy

    Published in Suicide & life-threatening behavior (01-12-2016)
    “…Past studies on suicide have investigated the association of firearm ownership and suicide risk in the United States. The aim of the present study was to build…”
    Get full text
    Journal Article
  4. 4

    Germinal Center B-Cell-like (GCB) Phenotype Predicts Improved Outcomes in Central Nervous System Diffuse Large B-Cell Lymphoma Patients Receiving Stereotactic Radiosurgery (SRS) by Azad, Farhan, Fekrmandi, Fatemeh, Amin, Mody, Goulenko, Victor, Wang, Katy, Attwood, Kris, Prasad, Dheerendra, Hernandez-Ilizaliturri, Francisco J.

    Published in Blood (02-11-2023)
    “…Background: Diffuse large B cell lymphoma (DLBCL) constitutes most cases of both primary and secondary central nervous system lymphoma (CNSL). They represent a…”
    Get full text
    Journal Article
  5. 5

    Real world outcomes of trilaciclib in ES-SCLC by Elijah, Joseph, Holdsworth, Allison, Wang, Katy, Attwood, Kristopher, Baron, Jeffrey, Przespolewski, Eugene, Jain, Prantesh, Dy, Grace K., Billias, Christina

    Published in Journal of clinical oncology (01-06-2023)
    “…e20637 Background: Carboplatin, etoposide, and atezolizumab (PEA) is the most widely used combination for first-line treatment of extensive-stage small cell…”
    Get full text
    Journal Article
  6. 6

    Prostate Cancer Screening Patterns Among Sexual and Gender Minority Individuals by Ma, Sung Jun, Oladeru, Oluwadamilola T., Wang, Katy, Attwood, Kristopher, Singh, Anurag K., Haas-Kogan, Daphne A., Neira, Paula M.

    Published in European urology (01-05-2021)
    “…One in six gay and bisexual men will be diagnosed with prostate cancer in their lifetime. Lesbian, gay, bisexual, and transgender (LGBT) populations are…”
    Get full text
    Journal Article
  7. 7

    Potential biomarkers for treatment response in advanced non-pancreatic neuroendocrine tumors by Sonti, Sahithi, Wang, Katy, Attwood, Kristopher, Minderman, Hans, Maguire, Orla, Ryan, Courtney, Sharma, Nitika, Konda, Bhavana, Iyer, Renuka V., Krishnamurthy, Anuradha

    Published in Journal of clinical oncology (20-01-2024)
    “…599 Background: Well-differentiated NETs are highly vascular and hence, inhibition of angiogenesis is of interest. VEGF, a key molecule in promoting…”
    Get full text
    Journal Article
  8. 8

    Systemic therapy for advanced anorectal squamous cell carcinomas: A single institutional experience by Boland, Patrick McKay, Wang, Katy, Kohen, Aniqa

    Published in Journal of clinical oncology (01-02-2016)
    “…Abstract only 728 Background: Anorectal squamous cell carcinomas (SCCs) are rare in the United States with < 10,000 cases annually. Uncommonly, patients…”
    Get full text
    Journal Article
  9. 9

    Trilaciclib use in extensive-stage small cell lung cancer (ES-SCLC): are clinical benefits seen in the real-world setting? by Elijah, Joseph, Jain, Prantesh, Holdsworth, Allison, Baron, Jeffrey, Przespolewski, Eugene, Wang, Katy, Attwood, Kristopher, Billias, Christina, Dy, Grace K.

    Published in Supportive care in cancer (01-09-2024)
    “…Background Trilaciclib, in comparison to placebo plus carboplatin, etoposide, ± atezolizumab (PEA), has shown significant reductions in incidence of severe…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Optimal Therapeutic Strategies in Relapsed/Refractory AML with Prior Exposure to Venetoclax Based Therapy by Bawek, Sawyer, Patel, Prutha, Wang, Katy, Attwood, Kristopher, Cronin, Tara, Fos, Melissa, Green, Steven, Sung, Pamela Jeannette, Thompson, James E, Griffiths, Elizabeth A., Wang, Eunice S, Przespolewski, Amanda C.

    Published in Blood (02-11-2023)
    “…Background: Acute myeloid leukemia (AML) is an aggressive hematological malignancy arising from immature myeloid progenitors with notoriously poor outcomes,…”
    Get full text
    Journal Article
  12. 12
  13. 13

    A multicentre phase 1b/2 study of tivozanib in patients with advanced inoperable hepatocellular carcinoma by Fountzilas, Christos, Gupta, Medhavi, Lee, Sunyoung, Krishnamurthi, Smitha, Estfan, Bassam, Wang, Katy, Attwood, Kristopher, Wilton, John, Bies, Robert, Bshara, Wiam, Iyer, Renuka

    Published in British journal of cancer (01-03-2020)
    “…Background Hepatocellular carcinoma (HCC) is a major cause of cancer-related death. It is a highly vascular tumour with multiple angiogenic factors, most…”
    Get full text
    Journal Article
  14. 14

    Breast and Cervical Cancer Screening Disparities in Transgender People by Oladeru, Oluwadamilola T., Ma, Sung Jun, Miccio, Joseph A., Wang, Katy, Attwood, Kristopher, Singh, Anurag K., Haas-Kogan, Daphne A., Neira, Paula M.

    Published in American journal of clinical oncology (01-03-2022)
    “…The population of individuals who identify as transgender (TG) is increasing in the United States, yet disparities in cancer screening services are widening…”
    Get full text
    Journal Article
  15. 15

    Cognitive skills assessment during robot‐assisted surgery: separating the wheat from the chaff by Guru, Khurshid A., Esfahani, Ehsan T., Raza, Syed J., Bhat, Rohit, Wang, Katy, Hammond, Yana, Wilding, Gregory, Peabody, James O., Chowriappa, Ashirwad J.

    Published in BJU international (01-01-2015)
    “…Objective To investigate the utility of cognitive assessment during robot‐assisted surgery (RAS) to define skills in terms of cognitive engagement, mental…”
    Get full text
    Journal Article
  16. 16

    Restrictive Intraoperative Fluid Rate is Associated with Improved Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy by Peng, June S., LaPiano, Jessica, Wang, Katy, Attwood, Kristopher, Skitzki, Joseph J., Kane, John M., Francescutti, Valerie A.

    Published in Annals of surgical oncology (01-01-2022)
    “…Background Management of patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CS/HIPEC) has historically favored liberal…”
    Get full text
    Journal Article
  17. 17

    Prostate cancer screening patterns among LGBT populations by Ma, Sung Jun, Oladeru, Oluwadamilola Temilade, Miccio, Joseph, Wang, Katy, Attwood, Kristopher, Singh, Anurag K, Haas-Kogan, Daphne A., Neira, Paula M

    Published in Journal of clinical oncology (20-05-2020)
    “…Abstract only e19077 Background: More than 10 million Americans identify themselves as lesbian, gay, bisexual, and transgender (LGBT), and the majority of…”
    Get full text
    Journal Article
  18. 18

    Breast and cervical cancer screening disparities among transgender patients by Oladeru, Oluwadamilola Temilade, Ma, Sung Jun, Miccio, Joseph, Wang, Katy, Attwood, Kristopher, Singh, Anurag K, Haas-Kogan, Daphne A., Neira, Paula M

    Published in Journal of clinical oncology (20-05-2020)
    “…Abstract only 7024 Background: Over a million Americans identify themselves as transgender and this population is growing. Transgender status was a…”
    Get full text
    Journal Article
  19. 19

    Oncologic Outcomes Following Robot-assisted Radical Cystectomy with Minimum 5-year Follow-up: The Roswell Park Cancer Institute Experience by Raza, Syed Johar, Al-Daghmin, Ali, Zhuo, Sharon, Mehboob, Zayn, Wang, Katy, Wilding, Gregory, Kauffman, Eric, Guru, Khurshid A

    Published in European urology (01-11-2014)
    “…Abstract Background Long-term oncologic outcomes following robot-assisted radical cystectomy (RARC) remain scarce. Objective To report long-term oncologic…”
    Get full text
    Journal Article
  20. 20